VITA 34 Future Growth
Future criteria checks 3/6
VITA 34 is forecast to grow earnings and revenue by 74.8% and 3.1% per annum respectively. EPS is expected to grow by 77.2% per annum. Return on equity is forecast to be 0.7% in 3 years.
Key information
74.8%
Earnings growth rate
77.2%
EPS growth rate
| Healthcare earnings growth | 23.6% |
| Revenue growth rate | 3.1% |
| Future return on equity | 0.7% |
| Analyst coverage | Low |
| Last updated | 04 Sep 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 86 | 1 | 7 | 9 | 1 |
| 12/31/2025 | 83 | 0 | 7 | 10 | 1 |
| 12/31/2024 | 81 | -1 | 5 | 7 | 1 |
| 6/30/2024 | 79 | 0 | 7 | 11 | N/A |
| 3/31/2024 | 78 | 0 | 7 | 11 | N/A |
| 12/31/2023 | 77 | -2 | 5 | 9 | N/A |
| 9/30/2023 | 75 | -25 | -5 | 0 | N/A |
| 6/30/2023 | 73 | -24 | -6 | 1 | N/A |
| 3/31/2023 | 71 | -27 | -10 | -3 | N/A |
| 12/31/2022 | 69 | -27 | -11 | -4 | N/A |
| 9/30/2022 | 63 | -12 | -6 | 0 | N/A |
| 6/30/2022 | 50 | -11 | -5 | -1 | N/A |
| 3/31/2022 | 39 | -6 | -1 | 2 | N/A |
| 12/31/2021 | 28 | -4 | 0 | 3 | N/A |
| 9/30/2021 | 21 | 0 | 2 | 3 | N/A |
| 6/30/2021 | 21 | 0 | 3 | 3 | N/A |
| 3/31/2021 | 20 | 1 | 3 | 4 | N/A |
| 12/31/2020 | 20 | 1 | 3 | 4 | N/A |
| 9/30/2020 | 20 | 1 | 4 | 5 | N/A |
| 6/30/2020 | 20 | 1 | 5 | 6 | N/A |
| 3/31/2020 | 20 | 1 | 5 | 6 | N/A |
| 12/31/2019 | 20 | 1 | 5 | 6 | N/A |
| 9/30/2019 | 20 | 1 | 5 | 6 | N/A |
| 6/30/2019 | 20 | 1 | 5 | 5 | N/A |
| 3/31/2019 | 20 | 1 | 5 | 5 | N/A |
| 12/31/2018 | 20 | 1 | 4 | 5 | N/A |
| 9/30/2018 | 21 | 2 | 3 | 4 | N/A |
| 6/30/2018 | 21 | 1 | 2 | 3 | N/A |
| 3/31/2018 | 20 | 0 | N/A | 2 | N/A |
| 12/31/2017 | 19 | 0 | N/A | 2 | N/A |
| 9/30/2017 | 18 | -1 | N/A | 2 | N/A |
| 6/30/2017 | 16 | -1 | N/A | 2 | N/A |
| 3/31/2017 | 17 | 1 | N/A | 2 | N/A |
| 12/31/2016 | 16 | 0 | N/A | 2 | N/A |
| 9/30/2016 | 16 | 2 | N/A | 1 | N/A |
| 6/30/2016 | 16 | 2 | N/A | 1 | N/A |
| 3/31/2016 | 15 | 2 | N/A | 1 | N/A |
| 12/31/2015 | 14 | 2 | N/A | 3 | N/A |
| 9/30/2015 | 14 | 1 | N/A | 2 | N/A |
| 6/30/2015 | 14 | 1 | N/A | 2 | N/A |
| 3/31/2015 | 14 | 1 | N/A | 2 | N/A |
| 12/31/2014 | 14 | 1 | N/A | 1 | N/A |
| 9/30/2014 | 14 | 1 | N/A | 2 | N/A |
| 6/30/2014 | 13 | 1 | N/A | 2 | N/A |
| 3/31/2014 | 14 | 1 | N/A | 2 | N/A |
| 12/31/2013 | 14 | 1 | N/A | 2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0NLV is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: 0NLV is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 0NLV is expected to become profitable in the next 3 years.
Revenue vs Market: 0NLV's revenue (3.1% per year) is forecast to grow slower than the UK market (3.6% per year).
High Growth Revenue: 0NLV's revenue (3.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 0NLV's Return on Equity is forecast to be low in 3 years time (0.7%).